PMD70 A Five-Year Markov Model Evaluating the Cost-Utility of NASHA/Dx for the Treatment of Fecal Incontinen A United States Perspective
Abstract
Authors
S.D. Wexner M. Bernstein C. Purdy R. Magar
S.D. Wexner M. Bernstein C. Purdy R. Magar
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now